Member Info for goupplease

What with Lanstead JH and DG declaring we are in safe hands .
Poor old Mulder is bashing himself . Why these weirdos exist baffles me , He will not change minds and he has no shares and should not be posting from his multiple handles .
Someday we will have an update

JH very good with notifying

Soup why did jh declare please ?

News will keep this share rolling bod .
I am sure DG poss AR reads this and your time keeping gets you a written warning , so say somthing even if its ....k off

Tr1

Mulder ,Do you think Lanstead would have invested without research ?

.

your skills are getting ledendary

Soup pr machine won

Commenting, Alastair Riddell, Executive Chairman of Nuformix, said: "We are pleased to see the progression of the application for the Company's first patent in relation to NXP004 to the publication stage. We believe NXP004 has significant potential and look forward to the granting of the Patent in due course. We are continuing to conduct further research and development activities on NXP004, as well as investigating future commercial opportunities. Whilst there remains much to be done, I look forward to making further announcements on our progress in the future."



Enquiries:

If a big pharmaceutical wants either of NFX drugs they can buy us out with their loose change and we have nice profits,

Well done JH no wonder she held firm , great work .
Lets hope they can back it up now after AB laid the foundations

I see them updating next week . DG checks this out .

well done SOUP you keep us going

Around 2 weeks to completion of the listing!

Today, #TLSA announced some very exciting news!!
We reported positive clinical data, from a Secondary Progressive Multiple Sclerosis (SPMS) patient treated for six months with intranasally administered foralumab.
https://tizianalifesciences.com/news-item?s=2022-03-10-tiziana-announces-positive-clinical-data-from-a-secondary-progressive-multiple-sclerosis-patient-treated-for-six-months-with-intranasally-administered-foralumab-a-fully-human-anti-cd3-monoclonal-antibody

got value on their broker account for accustem please ?

And they jump ship ?

Agreed Filter, lessons learnt.
We are crying out for news

The signals are all good .
We have been given positives on NPX002 and NPX004 .
Even if one out the two make it we should be in the money.
DG understands the drugs and what they can do , Not his biggest fan but he is not starting from scratch .
If it achieves our goals .great